Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Canakinumab in Caucasian patients with Yao Syndrome: a retrospective, single centre study

Trial Profile

Efficacy of Canakinumab in Caucasian patients with Yao Syndrome: a retrospective, single centre study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2018

At a glance

  • Drugs Canakinumab (Primary)
  • Indications Familial autosomal dominant periodic fever
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Nov 2018 New trial record
    • 24 Oct 2018 Results assessing efficacy of canakinumab in patients with Yao syndrome, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top